1. Home
  2. RYAAY vs KVUE Comparison

RYAAY vs KVUE Comparison

Compare RYAAY & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryanair Holdings plc

RYAAY

Ryanair Holdings plc

HOLD

Current Price

$55.02

Market Cap

31.8B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$19.01

Market Cap

36.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAAY
KVUE
Founded
1985
2022
Country
Ireland
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Specialty Chemicals
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
36.9B
IPO Year
2003
2023

Fundamental Metrics

Financial Performance
Metric
RYAAY
KVUE
Price
$55.02
$19.01
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$78.00
$19.45
AVG Volume (30 Days)
1.1M
18.1M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
1.54%
4.82%
EPS Growth
N/A
40.74
EPS
N/A
0.48
Revenue
N/A
$15,124,000,000.00
Revenue This Year
$11.99
$4.85
Revenue Next Year
$6.32
$2.63
P/E Ratio
$12.60
$39.17
Revenue Growth
N/A
N/A
52 Week Low
$53.14
$14.02
52 Week High
$74.24
$21.78

Technical Indicators

Market Signals
Indicator
RYAAY
KVUE
Relative Strength Index (RSI) 33.36 47.60
Support Level $53.22 $18.67
Resistance Level $61.54 $19.07
Average True Range (ATR) 1.07 0.44
MACD -0.39 -0.07
Stochastic Oscillator 3.99 27.62

Price Performance

Historical Comparison
RYAAY
KVUE

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: